Peptide science has expanded rapidly in recent decades, revealing molecules with intriguing signaling roles that may influence diverse regenerative and organizational processes within an organism.

Structure Therapeutics’ aleniglipron Phase 2 shows ~16% placebo-adjusted weight loss; a best-in-class oral GLP-1 with strong ...

A domestic research team has developed an artificial intelligence (AI) model that not only predicts whether a drug binds to a protein but also whether it actually turns the protein's function on or ...

Biological males in women’s sports have become a losing issue. But some ideological celebs and out-of-touch athletes still haven’t gotten the message. A new campaign from the ACLU defending ...

ZURICH & PHILADELPHIA & COPENHAGEN, Denmark--(BUSINESS WIRE)--InterAx Biotech Ltd (“InterAx”) and Alveus Therapeutics Inc. (“Alveus”) today announced a strategic research collaboration and licensing ...

Opioid receptors are fantastic targets for treating pain—but unfortunately, the drugs that target them can be addictive. Because the molecules suppress breathing and heart function, those drugs can ...

Tyler Fritsch is a 2 nd year student in the Microbiology, Immunology, and Infectious Disease training group where he works in Dr. Matosevic’s Lab in the IMPH Department. The Matosevic lab primarily ...

New research led by the University of Minnesota Medical School demonstrates that molecules acting as "molecular bumpers" and "molecular glues" can rewire G protein-coupled receptor (GPCR) signaling, ...

The adipose tissue regulates energy homeostasis, which is one of the vital processes for organismal survival, and its dysregulation causes metabolic diseases including obesity and type 2 diabetes.

Shares of Septerna Inc. were soaring in Wednesday trading after the biotech clinched a partnership with Wegovy and Ozempic parent Novo Nordisk to collaborate on oral obesity and Type 2 diabetes ...

The effects of gut microbiota on antiviral immunity have been well-documented in recent years, whereas a mechanistic understanding of microbiota-derived metabolite-related signaling pathways is still ...

The GPCR-targeting therapies market is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with cancer, the growing awareness ...